From June 11–15, 2025, PathFinder Lab members Sangjeong Ahn and Hyeseong Lee attended CVPR 2025 in Nashville, TN. With over 2,800 accepted papers, the event provided exposure to leading research in medical AI and foundation models. Key highlights included sessions with Kather Lab, Faisal Mahmood Lab, Paige, and new collaborations with Stony Brook University. The visit strengthened academic ties and inspired new directions in pathology image restoration.

From April 25–30, 2025, three members of the PathFinder Lab attended the AACR Annual Meeting in Chicago. Moonyoung Lee and Harim Chun presented research posters, while the team engaged with sessions focused on spatial omics, AI-driven pathology, and therapeutic targeting. The conference offered valuable perspectives on computational cancer biology and biomarker discovery. These insights directly inform and strengthen the lab’s current research directions.

2nd PathFinder Lab Workshop was held February 6-7 at Vivaldi Park in Hongcheon, combining skiing with scientific presentations on pathology image analysis, deep learning, and genomics data analysis. This blend of winter sports, research presentations, and social activities successfully advanced interdisciplinary projects while strengthening team collaboration.

REG 2025 pushes automatic pathology report generation by tasking participants to convert Pan-Asia gigapixel whole-slide images into clinically sound text. A 20,500-case dataset from six centers is provided; pretrained weights permitted, extra data barred; schedule extended amid server fixes.

Pathfinder Lab has been at the forefront of developing AI-powered software for analyzing digital pathology images, with a particular focus on cancer detection. Pathfinder Lab has been at the forefront of developing AI-powered software for analyzing digital pathology images.

Our strength lies in our partnerships. By collaborating with leading university hospitals, such as the University Hospital Zurich and Women’s Hospital, we’ve built a robust network that combines academic expertise with clinical insights.

One of our core goals is to democratize access to advanced diagnostic tools. We’re proud to announce that our software has been adopted by over 50 mid-sized hospitals across North America and Europe, enabling them to provide high-quality pathology services without the need for in-house expertise. Additionally, we’ve partnered with government health agencies in Canada and the UK to integrate our AI-driven diagnostics into national healthcare systems, improving diagnostic accuracy for unders

We’re excited to continue sharing our work with the global pathology community. Next month, Pathfinder Lab will be presenting at the International Conference on Medical Image Computing and Computer-Assisted Intervention (MICCAI) 2025, where we’ll introduce a new computational framework for kidney transplant outcome prediction.A

As we continue to innovate, our slogan—“Pioneering the Field of Digital Pathology with Challenge and Expertise”—remains at the heart of everything we do.